nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciprofloxacin—TOP2A—Epirubicin—uterine cancer	0.137	0.192	CbGbCtD
Ciprofloxacin—TOP2A—Etoposide—uterine cancer	0.107	0.149	CbGbCtD
Ciprofloxacin—TOP2A—Doxorubicin—uterine cancer	0.0729	0.102	CbGbCtD
Ciprofloxacin—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0654	0.0914	CbGbCtD
Ciprofloxacin—CYP3A7—Progesterone—uterine cancer	0.0654	0.0914	CbGbCtD
Ciprofloxacin—CYP3A5—Progesterone—uterine cancer	0.0491	0.0686	CbGbCtD
Ciprofloxacin—CYP1A2—Progesterone—uterine cancer	0.0365	0.0511	CbGbCtD
Ciprofloxacin—ABCB1—Progesterone—uterine cancer	0.0319	0.0446	CbGbCtD
Ciprofloxacin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0289	0.0404	CbGbCtD
Ciprofloxacin—ABCB1—Dactinomycin—uterine cancer	0.0253	0.0354	CbGbCtD
Ciprofloxacin—CYP3A5—Etoposide—uterine cancer	0.022	0.0307	CbGbCtD
Ciprofloxacin—CYP3A4—Progesterone—uterine cancer	0.0191	0.0267	CbGbCtD
Ciprofloxacin—CYP1A2—Etoposide—uterine cancer	0.0163	0.0228	CbGbCtD
Ciprofloxacin—ABCB1—Etoposide—uterine cancer	0.0143	0.02	CbGbCtD
Ciprofloxacin—ABCB1—Doxorubicin—uterine cancer	0.00975	0.0136	CbGbCtD
Ciprofloxacin—CYP3A4—Etoposide—uterine cancer	0.00856	0.012	CbGbCtD
Ciprofloxacin—CYP3A4—Doxorubicin—uterine cancer	0.00584	0.00816	CbGbCtD
Ciprofloxacin—TOP2A—Podofilox—Etoposide—uterine cancer	0.000617	0.136	CbGdCrCtD
Ciprofloxacin—TOP2A—Teniposide—Etoposide—uterine cancer	0.000617	0.136	CbGdCrCtD
Ciprofloxacin—TOP2A—myometrium—uterine cancer	0.000609	0.101	CbGeAlD
Ciprofloxacin—TOP2A—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.000504	0.111	CbGdCrCtD
Ciprofloxacin—TOP2A—uterine cervix—uterine cancer	0.000474	0.0784	CbGeAlD
Ciprofloxacin—TOP2A—decidua—uterine cancer	0.000452	0.0747	CbGeAlD
Ciprofloxacin—TOP2A—Methyltestosterone—Progesterone—uterine cancer	0.000439	0.0965	CbGdCrCtD
Ciprofloxacin—TOP2A—endometrium—uterine cancer	0.000429	0.0709	CbGeAlD
Ciprofloxacin—TOP2A—mammalian vulva—uterine cancer	0.000415	0.0686	CbGeAlD
Ciprofloxacin—TOP2A—uterus—uterine cancer	0.000395	0.0654	CbGeAlD
Ciprofloxacin—TOP2A—female gonad—uterine cancer	0.000323	0.0535	CbGeAlD
Ciprofloxacin—TOP2A—Daunorubicin—Epirubicin—uterine cancer	0.000322	0.0707	CbGdCrCtD
Ciprofloxacin—TOP2A—Doxorubicin—Epirubicin—uterine cancer	0.000322	0.0707	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Epirubicin—uterine cancer	0.000322	0.0707	CbGdCrCtD
Ciprofloxacin—TOP2A—vagina—uterine cancer	0.000321	0.0532	CbGeAlD
Ciprofloxacin—TOP2A—Daunorubicin—Doxorubicin—uterine cancer	0.000298	0.0655	CbGdCrCtD
Ciprofloxacin—TOP2A—Epirubicin—Doxorubicin—uterine cancer	0.000298	0.0655	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Doxorubicin—uterine cancer	0.000298	0.0655	CbGdCrCtD
Ciprofloxacin—TOP2A—Norethindrone—Progesterone—uterine cancer	0.000286	0.0629	CbGdCrCtD
Ciprofloxacin—TOP2A—Levonorgestrel—Progesterone—uterine cancer	0.000228	0.05	CbGdCrCtD
Ciprofloxacin—CYP3A5—uterine cervix—uterine cancer	0.000219	0.0363	CbGeAlD
Ciprofloxacin—CYP1A2—renal system—uterine cancer	0.000213	0.0352	CbGeAlD
Ciprofloxacin—TOP2A—lymph node—uterine cancer	0.000208	0.0344	CbGeAlD
Ciprofloxacin—CYP3A5—renal system—uterine cancer	0.000205	0.034	CbGeAlD
Ciprofloxacin—CYP3A4—renal system—uterine cancer	0.000154	0.0255	CbGeAlD
Ciprofloxacin—ABCB1—myometrium—uterine cancer	0.00015	0.0248	CbGeAlD
Ciprofloxacin—CYP3A5—female gonad—uterine cancer	0.00015	0.0247	CbGeAlD
Ciprofloxacin—CYP3A5—vagina—uterine cancer	0.000149	0.0246	CbGeAlD
Ciprofloxacin—CYP3A4—female reproductive system—uterine cancer	0.000123	0.0204	CbGeAlD
Ciprofloxacin—ABCB1—epithelium—uterine cancer	0.000118	0.0194	CbGeAlD
Ciprofloxacin—ABCB1—uterine cervix—uterine cancer	0.000117	0.0193	CbGeAlD
Ciprofloxacin—ABCB1—decidua—uterine cancer	0.000111	0.0184	CbGeAlD
Ciprofloxacin—ABCB1—renal system—uterine cancer	0.000109	0.018	CbGeAlD
Ciprofloxacin—ABCB1—endometrium—uterine cancer	0.000105	0.0174	CbGeAlD
Ciprofloxacin—ABCB1—mammalian vulva—uterine cancer	0.000102	0.0169	CbGeAlD
Ciprofloxacin—ABCB1—uterus—uterine cancer	9.71e-05	0.0161	CbGeAlD
Ciprofloxacin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	8.85e-05	0.0223	CbGpPWpGaD
Ciprofloxacin—ABCB1—female reproductive system—uterine cancer	8.73e-05	0.0144	CbGeAlD
Ciprofloxacin—Neutropenia—Epirubicin—uterine cancer	8.71e-05	0.000322	CcSEcCtD
Ciprofloxacin—Abdominal distension—Doxorubicin—uterine cancer	8.68e-05	0.000321	CcSEcCtD
Ciprofloxacin—Dysphagia—Doxorubicin—uterine cancer	8.62e-05	0.000319	CcSEcCtD
Ciprofloxacin—Asthma—Doxorubicin—uterine cancer	8.62e-05	0.000319	CcSEcCtD
Ciprofloxacin—Pollakiuria—Epirubicin—uterine cancer	8.6e-05	0.000319	CcSEcCtD
Ciprofloxacin—Eosinophilia—Doxorubicin—uterine cancer	8.53e-05	0.000316	CcSEcCtD
Ciprofloxacin—Photosensitivity reaction—Epirubicin—uterine cancer	8.5e-05	0.000315	CcSEcCtD
Ciprofloxacin—Paraesthesia—Etoposide—uterine cancer	8.48e-05	0.000314	CcSEcCtD
Ciprofloxacin—Pancreatitis—Doxorubicin—uterine cancer	8.45e-05	0.000313	CcSEcCtD
Ciprofloxacin—Dyspnoea—Etoposide—uterine cancer	8.42e-05	0.000312	CcSEcCtD
Ciprofloxacin—Hyperglycaemia—Epirubicin—uterine cancer	8.4e-05	0.000311	CcSEcCtD
Ciprofloxacin—Somnolence—Etoposide—uterine cancer	8.4e-05	0.000311	CcSEcCtD
Ciprofloxacin—Angina pectoris—Doxorubicin—uterine cancer	8.39e-05	0.000311	CcSEcCtD
Ciprofloxacin—ABCB1—ABC-family proteins mediated transport—ABCC9—uterine cancer	8.38e-05	0.0211	CbGpPWpGaD
Ciprofloxacin—Pneumonia—Epirubicin—uterine cancer	8.35e-05	0.000309	CcSEcCtD
Ciprofloxacin—Infestation NOS—Epirubicin—uterine cancer	8.3e-05	0.000307	CcSEcCtD
Ciprofloxacin—Drowsiness—Epirubicin—uterine cancer	8.3e-05	0.000307	CcSEcCtD
Ciprofloxacin—Infestation—Epirubicin—uterine cancer	8.3e-05	0.000307	CcSEcCtD
Ciprofloxacin—Vomiting—Dactinomycin—uterine cancer	8.3e-05	0.000307	CcSEcCtD
Ciprofloxacin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	8.23e-05	0.000305	CcSEcCtD
Ciprofloxacin—Rash—Dactinomycin—uterine cancer	8.23e-05	0.000305	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	8.22e-05	0.0207	CbGpPWpGaD
Ciprofloxacin—Decreased appetite—Etoposide—uterine cancer	8.21e-05	0.000304	CcSEcCtD
Ciprofloxacin—Pancytopenia—Doxorubicin—uterine cancer	8.18e-05	0.000303	CcSEcCtD
Ciprofloxacin—Renal failure—Epirubicin—uterine cancer	8.16e-05	0.000302	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Etoposide—uterine cancer	8.16e-05	0.000302	CcSEcCtD
Ciprofloxacin—Fatigue—Etoposide—uterine cancer	8.15e-05	0.000302	CcSEcCtD
Ciprofloxacin—Neuropathy peripheral—Epirubicin—uterine cancer	8.14e-05	0.000301	CcSEcCtD
Ciprofloxacin—Stomatitis—Epirubicin—uterine cancer	8.09e-05	0.0003	CcSEcCtD
Ciprofloxacin—Jaundice—Epirubicin—uterine cancer	8.09e-05	0.0003	CcSEcCtD
Ciprofloxacin—Pain—Etoposide—uterine cancer	8.08e-05	0.000299	CcSEcCtD
Ciprofloxacin—Constipation—Etoposide—uterine cancer	8.08e-05	0.000299	CcSEcCtD
Ciprofloxacin—Conjunctivitis—Epirubicin—uterine cancer	8.07e-05	0.000299	CcSEcCtD
Ciprofloxacin—Neutropenia—Doxorubicin—uterine cancer	8.06e-05	0.000298	CcSEcCtD
Ciprofloxacin—Dysuria—Doxorubicin—uterine cancer	8.06e-05	0.000298	CcSEcCtD
Ciprofloxacin—Sweating—Epirubicin—uterine cancer	7.96e-05	0.000295	CcSEcCtD
Ciprofloxacin—Pollakiuria—Doxorubicin—uterine cancer	7.96e-05	0.000295	CcSEcCtD
Ciprofloxacin—ABCB1—female gonad—uterine cancer	7.94e-05	0.0131	CbGeAlD
Ciprofloxacin—Haematuria—Epirubicin—uterine cancer	7.92e-05	0.000293	CcSEcCtD
Ciprofloxacin—ABCB1—vagina—uterine cancer	7.9e-05	0.0131	CbGeAlD
Ciprofloxacin—Photosensitivity reaction—Doxorubicin—uterine cancer	7.87e-05	0.000291	CcSEcCtD
Ciprofloxacin—Hepatobiliary disease—Epirubicin—uterine cancer	7.85e-05	0.000291	CcSEcCtD
Ciprofloxacin—Epistaxis—Epirubicin—uterine cancer	7.83e-05	0.00029	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Etoposide—uterine cancer	7.79e-05	0.000288	CcSEcCtD
Ciprofloxacin—Hyperglycaemia—Doxorubicin—uterine cancer	7.77e-05	0.000288	CcSEcCtD
Ciprofloxacin—Nausea—Dactinomycin—uterine cancer	7.75e-05	0.000287	CcSEcCtD
Ciprofloxacin—Agranulocytosis—Epirubicin—uterine cancer	7.75e-05	0.000287	CcSEcCtD
Ciprofloxacin—Pneumonia—Doxorubicin—uterine cancer	7.73e-05	0.000286	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Etoposide—uterine cancer	7.73e-05	0.000286	CcSEcCtD
Ciprofloxacin—Drowsiness—Doxorubicin—uterine cancer	7.68e-05	0.000285	CcSEcCtD
Ciprofloxacin—Infestation NOS—Doxorubicin—uterine cancer	7.68e-05	0.000285	CcSEcCtD
Ciprofloxacin—Infestation—Doxorubicin—uterine cancer	7.68e-05	0.000285	CcSEcCtD
Ciprofloxacin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	7.62e-05	0.000282	CcSEcCtD
Ciprofloxacin—Bradycardia—Epirubicin—uterine cancer	7.59e-05	0.000281	CcSEcCtD
Ciprofloxacin—Renal failure—Doxorubicin—uterine cancer	7.55e-05	0.00028	CcSEcCtD
Ciprofloxacin—Neuropathy peripheral—Doxorubicin—uterine cancer	7.53e-05	0.000279	CcSEcCtD
Ciprofloxacin—Urticaria—Etoposide—uterine cancer	7.51e-05	0.000278	CcSEcCtD
Ciprofloxacin—Haemoglobin—Epirubicin—uterine cancer	7.49e-05	0.000277	CcSEcCtD
Ciprofloxacin—Jaundice—Doxorubicin—uterine cancer	7.49e-05	0.000277	CcSEcCtD
Ciprofloxacin—Stomatitis—Doxorubicin—uterine cancer	7.49e-05	0.000277	CcSEcCtD
Ciprofloxacin—Rhinitis—Epirubicin—uterine cancer	7.47e-05	0.000277	CcSEcCtD
Ciprofloxacin—Abdominal pain—Etoposide—uterine cancer	7.47e-05	0.000277	CcSEcCtD
Ciprofloxacin—Body temperature increased—Etoposide—uterine cancer	7.47e-05	0.000277	CcSEcCtD
Ciprofloxacin—Conjunctivitis—Doxorubicin—uterine cancer	7.47e-05	0.000277	CcSEcCtD
Ciprofloxacin—Haemorrhage—Epirubicin—uterine cancer	7.45e-05	0.000276	CcSEcCtD
Ciprofloxacin—Hepatitis—Epirubicin—uterine cancer	7.45e-05	0.000276	CcSEcCtD
Ciprofloxacin—Hypoaesthesia—Epirubicin—uterine cancer	7.42e-05	0.000275	CcSEcCtD
Ciprofloxacin—Pharyngitis—Epirubicin—uterine cancer	7.4e-05	0.000274	CcSEcCtD
Ciprofloxacin—Sweating—Doxorubicin—uterine cancer	7.37e-05	0.000273	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Epirubicin—uterine cancer	7.36e-05	0.000273	CcSEcCtD
Ciprofloxacin—Oedema peripheral—Epirubicin—uterine cancer	7.34e-05	0.000272	CcSEcCtD
Ciprofloxacin—Haematuria—Doxorubicin—uterine cancer	7.33e-05	0.000271	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Epirubicin—uterine cancer	7.33e-05	0.000271	CcSEcCtD
Ciprofloxacin—Urethral disorder—Epirubicin—uterine cancer	7.31e-05	0.000271	CcSEcCtD
Ciprofloxacin—Hepatobiliary disease—Doxorubicin—uterine cancer	7.27e-05	0.000269	CcSEcCtD
Ciprofloxacin—Epistaxis—Doxorubicin—uterine cancer	7.25e-05	0.000268	CcSEcCtD
Ciprofloxacin—Visual impairment—Epirubicin—uterine cancer	7.18e-05	0.000266	CcSEcCtD
Ciprofloxacin—Agranulocytosis—Doxorubicin—uterine cancer	7.17e-05	0.000266	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Epirubicin—uterine cancer	7.05e-05	0.000261	CcSEcCtD
Ciprofloxacin—Bradycardia—Doxorubicin—uterine cancer	7.02e-05	0.00026	CcSEcCtD
Ciprofloxacin—Eye disorder—Epirubicin—uterine cancer	6.97e-05	0.000258	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Etoposide—uterine cancer	6.96e-05	0.000258	CcSEcCtD
Ciprofloxacin—Tinnitus—Epirubicin—uterine cancer	6.95e-05	0.000257	CcSEcCtD
Ciprofloxacin—Haemoglobin—Doxorubicin—uterine cancer	6.93e-05	0.000257	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Epirubicin—uterine cancer	6.92e-05	0.000256	CcSEcCtD
Ciprofloxacin—Flushing—Epirubicin—uterine cancer	6.92e-05	0.000256	CcSEcCtD
Ciprofloxacin—Rhinitis—Doxorubicin—uterine cancer	6.92e-05	0.000256	CcSEcCtD
Ciprofloxacin—Haemorrhage—Doxorubicin—uterine cancer	6.9e-05	0.000255	CcSEcCtD
Ciprofloxacin—Hepatitis—Doxorubicin—uterine cancer	6.9e-05	0.000255	CcSEcCtD
Ciprofloxacin—Hypoaesthesia—Doxorubicin—uterine cancer	6.86e-05	0.000254	CcSEcCtD
Ciprofloxacin—Pharyngitis—Doxorubicin—uterine cancer	6.85e-05	0.000253	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Doxorubicin—uterine cancer	6.81e-05	0.000252	CcSEcCtD
Ciprofloxacin—Oedema peripheral—Doxorubicin—uterine cancer	6.79e-05	0.000252	CcSEcCtD
Ciprofloxacin—Asthenia—Etoposide—uterine cancer	6.78e-05	0.000251	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Doxorubicin—uterine cancer	6.78e-05	0.000251	CcSEcCtD
Ciprofloxacin—Angiopathy—Epirubicin—uterine cancer	6.76e-05	0.00025	CcSEcCtD
Ciprofloxacin—Urethral disorder—Doxorubicin—uterine cancer	6.76e-05	0.00025	CcSEcCtD
Ciprofloxacin—Immune system disorder—Epirubicin—uterine cancer	6.73e-05	0.000249	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Epirubicin—uterine cancer	6.72e-05	0.000249	CcSEcCtD
Ciprofloxacin—Chills—Epirubicin—uterine cancer	6.69e-05	0.000248	CcSEcCtD
Ciprofloxacin—Pruritus—Etoposide—uterine cancer	6.68e-05	0.000248	CcSEcCtD
Ciprofloxacin—Arrhythmia—Epirubicin—uterine cancer	6.66e-05	0.000247	CcSEcCtD
Ciprofloxacin—Visual impairment—Doxorubicin—uterine cancer	6.65e-05	0.000246	CcSEcCtD
Ciprofloxacin—Alopecia—Epirubicin—uterine cancer	6.59e-05	0.000244	CcSEcCtD
Ciprofloxacin—Mental disorder—Epirubicin—uterine cancer	6.53e-05	0.000242	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Doxorubicin—uterine cancer	6.52e-05	0.000241	CcSEcCtD
Ciprofloxacin—Malnutrition—Epirubicin—uterine cancer	6.49e-05	0.00024	CcSEcCtD
Ciprofloxacin—Erythema—Epirubicin—uterine cancer	6.49e-05	0.00024	CcSEcCtD
Ciprofloxacin—Diarrhoea—Etoposide—uterine cancer	6.46e-05	0.000239	CcSEcCtD
Ciprofloxacin—Eye disorder—Doxorubicin—uterine cancer	6.45e-05	0.000239	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—STAR—uterine cancer	6.43e-05	0.0162	CbGpPWpGaD
Ciprofloxacin—Tinnitus—Doxorubicin—uterine cancer	6.43e-05	0.000238	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Doxorubicin—uterine cancer	6.4e-05	0.000237	CcSEcCtD
Ciprofloxacin—Flushing—Doxorubicin—uterine cancer	6.4e-05	0.000237	CcSEcCtD
Ciprofloxacin—Flatulence—Epirubicin—uterine cancer	6.39e-05	0.000237	CcSEcCtD
Ciprofloxacin—Tension—Epirubicin—uterine cancer	6.37e-05	0.000236	CcSEcCtD
Ciprofloxacin—Dysgeusia—Epirubicin—uterine cancer	6.35e-05	0.000235	CcSEcCtD
Ciprofloxacin—Nervousness—Epirubicin—uterine cancer	6.3e-05	0.000233	CcSEcCtD
Ciprofloxacin—Back pain—Epirubicin—uterine cancer	6.28e-05	0.000232	CcSEcCtD
Ciprofloxacin—Angiopathy—Doxorubicin—uterine cancer	6.26e-05	0.000232	CcSEcCtD
Ciprofloxacin—Dizziness—Etoposide—uterine cancer	6.25e-05	0.000231	CcSEcCtD
Ciprofloxacin—Muscle spasms—Epirubicin—uterine cancer	6.24e-05	0.000231	CcSEcCtD
Ciprofloxacin—Immune system disorder—Doxorubicin—uterine cancer	6.23e-05	0.000231	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Doxorubicin—uterine cancer	6.22e-05	0.00023	CcSEcCtD
Ciprofloxacin—Chills—Doxorubicin—uterine cancer	6.19e-05	0.000229	CcSEcCtD
Ciprofloxacin—Arrhythmia—Doxorubicin—uterine cancer	6.16e-05	0.000228	CcSEcCtD
Ciprofloxacin—Vision blurred—Epirubicin—uterine cancer	6.12e-05	0.000226	CcSEcCtD
Ciprofloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	6.11e-05	0.0154	CbGpPWpGaD
Ciprofloxacin—Alopecia—Doxorubicin—uterine cancer	6.1e-05	0.000226	CcSEcCtD
Ciprofloxacin—Mental disorder—Doxorubicin—uterine cancer	6.04e-05	0.000224	CcSEcCtD
Ciprofloxacin—CYP3A7—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	6.03e-05	0.0152	CbGpPWpGaD
Ciprofloxacin—Ill-defined disorder—Epirubicin—uterine cancer	6.02e-05	0.000223	CcSEcCtD
Ciprofloxacin—Vomiting—Etoposide—uterine cancer	6.01e-05	0.000222	CcSEcCtD
Ciprofloxacin—Erythema—Doxorubicin—uterine cancer	6e-05	0.000222	CcSEcCtD
Ciprofloxacin—Malnutrition—Doxorubicin—uterine cancer	6e-05	0.000222	CcSEcCtD
Ciprofloxacin—Anaemia—Epirubicin—uterine cancer	6e-05	0.000222	CcSEcCtD
Ciprofloxacin—Agitation—Epirubicin—uterine cancer	5.96e-05	0.000221	CcSEcCtD
Ciprofloxacin—Rash—Etoposide—uterine cancer	5.96e-05	0.000221	CcSEcCtD
Ciprofloxacin—Dermatitis—Etoposide—uterine cancer	5.95e-05	0.00022	CcSEcCtD
Ciprofloxacin—Headache—Etoposide—uterine cancer	5.92e-05	0.000219	CcSEcCtD
Ciprofloxacin—Flatulence—Doxorubicin—uterine cancer	5.92e-05	0.000219	CcSEcCtD
Ciprofloxacin—Tension—Doxorubicin—uterine cancer	5.89e-05	0.000218	CcSEcCtD
Ciprofloxacin—Dysgeusia—Doxorubicin—uterine cancer	5.88e-05	0.000218	CcSEcCtD
Ciprofloxacin—Malaise—Epirubicin—uterine cancer	5.85e-05	0.000217	CcSEcCtD
Ciprofloxacin—Nervousness—Doxorubicin—uterine cancer	5.83e-05	0.000216	CcSEcCtD
Ciprofloxacin—Vertigo—Epirubicin—uterine cancer	5.83e-05	0.000216	CcSEcCtD
Ciprofloxacin—Syncope—Epirubicin—uterine cancer	5.82e-05	0.000215	CcSEcCtD
Ciprofloxacin—Leukopenia—Epirubicin—uterine cancer	5.81e-05	0.000215	CcSEcCtD
Ciprofloxacin—Back pain—Doxorubicin—uterine cancer	5.81e-05	0.000215	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—RRM2—uterine cancer	5.79e-05	0.0146	CbGpPWpGaD
Ciprofloxacin—Muscle spasms—Doxorubicin—uterine cancer	5.77e-05	0.000214	CcSEcCtD
Ciprofloxacin—Palpitations—Epirubicin—uterine cancer	5.73e-05	0.000212	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Epirubicin—uterine cancer	5.7e-05	0.000211	CcSEcCtD
Ciprofloxacin—Cough—Epirubicin—uterine cancer	5.66e-05	0.00021	CcSEcCtD
Ciprofloxacin—Vision blurred—Doxorubicin—uterine cancer	5.66e-05	0.00021	CcSEcCtD
Ciprofloxacin—Convulsion—Epirubicin—uterine cancer	5.62e-05	0.000208	CcSEcCtD
Ciprofloxacin—Nausea—Etoposide—uterine cancer	5.61e-05	0.000208	CcSEcCtD
Ciprofloxacin—Hypertension—Epirubicin—uterine cancer	5.6e-05	0.000207	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Doxorubicin—uterine cancer	5.57e-05	0.000206	CcSEcCtD
Ciprofloxacin—Anaemia—Doxorubicin—uterine cancer	5.55e-05	0.000206	CcSEcCtD
Ciprofloxacin—Arthralgia—Epirubicin—uterine cancer	5.52e-05	0.000205	CcSEcCtD
Ciprofloxacin—Myalgia—Epirubicin—uterine cancer	5.52e-05	0.000205	CcSEcCtD
Ciprofloxacin—Chest pain—Epirubicin—uterine cancer	5.52e-05	0.000205	CcSEcCtD
Ciprofloxacin—Agitation—Doxorubicin—uterine cancer	5.52e-05	0.000204	CcSEcCtD
Ciprofloxacin—Anxiety—Epirubicin—uterine cancer	5.51e-05	0.000204	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	5.49e-05	0.000203	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	5.46e-05	0.0138	CbGpPWpGaD
Ciprofloxacin—Discomfort—Epirubicin—uterine cancer	5.46e-05	0.000202	CcSEcCtD
Ciprofloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—uterine cancer	5.42e-05	0.0137	CbGpPWpGaD
Ciprofloxacin—Malaise—Doxorubicin—uterine cancer	5.41e-05	0.000201	CcSEcCtD
Ciprofloxacin—Dry mouth—Epirubicin—uterine cancer	5.4e-05	0.0002	CcSEcCtD
Ciprofloxacin—Vertigo—Doxorubicin—uterine cancer	5.39e-05	0.0002	CcSEcCtD
Ciprofloxacin—Syncope—Doxorubicin—uterine cancer	5.38e-05	0.000199	CcSEcCtD
Ciprofloxacin—Leukopenia—Doxorubicin—uterine cancer	5.37e-05	0.000199	CcSEcCtD
Ciprofloxacin—Confusional state—Epirubicin—uterine cancer	5.34e-05	0.000198	CcSEcCtD
Ciprofloxacin—Palpitations—Doxorubicin—uterine cancer	5.31e-05	0.000196	CcSEcCtD
Ciprofloxacin—Oedema—Epirubicin—uterine cancer	5.3e-05	0.000196	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Epirubicin—uterine cancer	5.3e-05	0.000196	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Doxorubicin—uterine cancer	5.28e-05	0.000195	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—HNF1B—uterine cancer	5.24e-05	0.0132	CbGpPWpGaD
Ciprofloxacin—Cough—Doxorubicin—uterine cancer	5.24e-05	0.000194	CcSEcCtD
Ciprofloxacin—Shock—Epirubicin—uterine cancer	5.21e-05	0.000193	CcSEcCtD
Ciprofloxacin—Convulsion—Doxorubicin—uterine cancer	5.2e-05	0.000193	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Epirubicin—uterine cancer	5.19e-05	0.000192	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Epirubicin—uterine cancer	5.19e-05	0.000192	CcSEcCtD
Ciprofloxacin—Hypertension—Doxorubicin—uterine cancer	5.18e-05	0.000192	CcSEcCtD
Ciprofloxacin—Tachycardia—Epirubicin—uterine cancer	5.17e-05	0.000191	CcSEcCtD
Ciprofloxacin—Skin disorder—Epirubicin—uterine cancer	5.14e-05	0.00019	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Epirubicin—uterine cancer	5.12e-05	0.00019	CcSEcCtD
Ciprofloxacin—Arthralgia—Doxorubicin—uterine cancer	5.11e-05	0.000189	CcSEcCtD
Ciprofloxacin—Myalgia—Doxorubicin—uterine cancer	5.11e-05	0.000189	CcSEcCtD
Ciprofloxacin—Chest pain—Doxorubicin—uterine cancer	5.11e-05	0.000189	CcSEcCtD
Ciprofloxacin—ABCB1—lymph node—uterine cancer	5.11e-05	0.00845	CbGeAlD
Ciprofloxacin—Anxiety—Doxorubicin—uterine cancer	5.09e-05	0.000189	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	5.08e-05	0.000188	CcSEcCtD
Ciprofloxacin—Discomfort—Doxorubicin—uterine cancer	5.05e-05	0.000187	CcSEcCtD
Ciprofloxacin—Anorexia—Epirubicin—uterine cancer	5.05e-05	0.000187	CcSEcCtD
Ciprofloxacin—Dry mouth—Doxorubicin—uterine cancer	5e-05	0.000185	CcSEcCtD
Ciprofloxacin—CYP3A7—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	4.95e-05	0.0125	CbGpPWpGaD
Ciprofloxacin—Hypotension—Epirubicin—uterine cancer	4.95e-05	0.000183	CcSEcCtD
Ciprofloxacin—Confusional state—Doxorubicin—uterine cancer	4.94e-05	0.000183	CcSEcCtD
Ciprofloxacin—Oedema—Doxorubicin—uterine cancer	4.9e-05	0.000181	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Doxorubicin—uterine cancer	4.9e-05	0.000181	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Epirubicin—uterine cancer	4.83e-05	0.000179	CcSEcCtD
Ciprofloxacin—Shock—Doxorubicin—uterine cancer	4.82e-05	0.000179	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Doxorubicin—uterine cancer	4.81e-05	0.000178	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Doxorubicin—uterine cancer	4.8e-05	0.000178	CcSEcCtD
Ciprofloxacin—Insomnia—Epirubicin—uterine cancer	4.79e-05	0.000177	CcSEcCtD
Ciprofloxacin—Tachycardia—Doxorubicin—uterine cancer	4.78e-05	0.000177	CcSEcCtD
Ciprofloxacin—Skin disorder—Doxorubicin—uterine cancer	4.76e-05	0.000176	CcSEcCtD
Ciprofloxacin—Paraesthesia—Epirubicin—uterine cancer	4.76e-05	0.000176	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Doxorubicin—uterine cancer	4.74e-05	0.000175	CcSEcCtD
Ciprofloxacin—Dyspnoea—Epirubicin—uterine cancer	4.72e-05	0.000175	CcSEcCtD
Ciprofloxacin—Somnolence—Epirubicin—uterine cancer	4.71e-05	0.000174	CcSEcCtD
Ciprofloxacin—Anorexia—Doxorubicin—uterine cancer	4.67e-05	0.000173	CcSEcCtD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—AKR1B10—uterine cancer	4.67e-05	0.0118	CbGpPWpGaD
Ciprofloxacin—Dyspepsia—Epirubicin—uterine cancer	4.66e-05	0.000173	CcSEcCtD
Ciprofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—uterine cancer	4.64e-05	0.0117	CbGpPWpGaD
Ciprofloxacin—Decreased appetite—Epirubicin—uterine cancer	4.6e-05	0.00017	CcSEcCtD
Ciprofloxacin—Hypotension—Doxorubicin—uterine cancer	4.58e-05	0.00017	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Epirubicin—uterine cancer	4.57e-05	0.000169	CcSEcCtD
Ciprofloxacin—Fatigue—Epirubicin—uterine cancer	4.57e-05	0.000169	CcSEcCtD
Ciprofloxacin—Constipation—Epirubicin—uterine cancer	4.53e-05	0.000168	CcSEcCtD
Ciprofloxacin—Pain—Epirubicin—uterine cancer	4.53e-05	0.000168	CcSEcCtD
Ciprofloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	4.5e-05	0.0113	CbGpPWpGaD
Ciprofloxacin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	4.46e-05	0.000165	CcSEcCtD
Ciprofloxacin—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine cancer	4.44e-05	0.0112	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	4.44e-05	0.0112	CbGpPWpGaD
Ciprofloxacin—Insomnia—Doxorubicin—uterine cancer	4.43e-05	0.000164	CcSEcCtD
Ciprofloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	4.42e-05	0.0111	CbGpPWpGaD
Ciprofloxacin—Paraesthesia—Doxorubicin—uterine cancer	4.4e-05	0.000163	CcSEcCtD
Ciprofloxacin—Dyspnoea—Doxorubicin—uterine cancer	4.37e-05	0.000162	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Epirubicin—uterine cancer	4.36e-05	0.000162	CcSEcCtD
Ciprofloxacin—CYP3A5—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	4.36e-05	0.011	CbGpPWpGaD
Ciprofloxacin—Somnolence—Doxorubicin—uterine cancer	4.36e-05	0.000161	CcSEcCtD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—AKR1B1—uterine cancer	4.34e-05	0.0109	CbGpPWpGaD
Ciprofloxacin—Gastrointestinal pain—Epirubicin—uterine cancer	4.33e-05	0.00016	CcSEcCtD
Ciprofloxacin—Dyspepsia—Doxorubicin—uterine cancer	4.31e-05	0.00016	CcSEcCtD
Ciprofloxacin—Decreased appetite—Doxorubicin—uterine cancer	4.26e-05	0.000158	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.23e-05	0.000157	CcSEcCtD
Ciprofloxacin—Fatigue—Doxorubicin—uterine cancer	4.22e-05	0.000156	CcSEcCtD
Ciprofloxacin—Urticaria—Epirubicin—uterine cancer	4.21e-05	0.000156	CcSEcCtD
Ciprofloxacin—Constipation—Doxorubicin—uterine cancer	4.19e-05	0.000155	CcSEcCtD
Ciprofloxacin—Pain—Doxorubicin—uterine cancer	4.19e-05	0.000155	CcSEcCtD
Ciprofloxacin—Abdominal pain—Epirubicin—uterine cancer	4.19e-05	0.000155	CcSEcCtD
Ciprofloxacin—Body temperature increased—Epirubicin—uterine cancer	4.19e-05	0.000155	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Doxorubicin—uterine cancer	4.04e-05	0.00015	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Doxorubicin—uterine cancer	4.01e-05	0.000148	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Epirubicin—uterine cancer	3.9e-05	0.000144	CcSEcCtD
Ciprofloxacin—Urticaria—Doxorubicin—uterine cancer	3.89e-05	0.000144	CcSEcCtD
Ciprofloxacin—Abdominal pain—Doxorubicin—uterine cancer	3.87e-05	0.000143	CcSEcCtD
Ciprofloxacin—Body temperature increased—Doxorubicin—uterine cancer	3.87e-05	0.000143	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—MLH3—uterine cancer	3.83e-05	0.00964	CbGpPWpGaD
Ciprofloxacin—Asthenia—Epirubicin—uterine cancer	3.8e-05	0.000141	CcSEcCtD
Ciprofloxacin—Pruritus—Epirubicin—uterine cancer	3.75e-05	0.000139	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	3.72e-05	0.00936	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	3.72e-05	0.00936	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	3.64e-05	0.00919	CbGpPWpGaD
Ciprofloxacin—Diarrhoea—Epirubicin—uterine cancer	3.62e-05	0.000134	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Doxorubicin—uterine cancer	3.61e-05	0.000134	CcSEcCtD
Ciprofloxacin—TOP2A—Gastric Cancer Network 2—TP53—uterine cancer	3.6e-05	0.00908	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	3.58e-05	0.00903	CbGpPWpGaD
Ciprofloxacin—Asthenia—Doxorubicin—uterine cancer	3.52e-05	0.00013	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	3.5e-05	0.00883	CbGpPWpGaD
Ciprofloxacin—Dizziness—Epirubicin—uterine cancer	3.5e-05	0.00013	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	3.49e-05	0.0088	CbGpPWpGaD
Ciprofloxacin—Pruritus—Doxorubicin—uterine cancer	3.47e-05	0.000128	CcSEcCtD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—AKR1B10—uterine cancer	3.37e-05	0.0085	CbGpPWpGaD
Ciprofloxacin—Vomiting—Epirubicin—uterine cancer	3.37e-05	0.000125	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—EZH2—uterine cancer	3.36e-05	0.00848	CbGpPWpGaD
Ciprofloxacin—Diarrhoea—Doxorubicin—uterine cancer	3.35e-05	0.000124	CcSEcCtD
Ciprofloxacin—Rash—Epirubicin—uterine cancer	3.34e-05	0.000124	CcSEcCtD
Ciprofloxacin—Dermatitis—Epirubicin—uterine cancer	3.34e-05	0.000124	CcSEcCtD
Ciprofloxacin—Headache—Epirubicin—uterine cancer	3.32e-05	0.000123	CcSEcCtD
Ciprofloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	3.25e-05	0.00819	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	3.25e-05	0.00819	CbGpPWpGaD
Ciprofloxacin—Dizziness—Doxorubicin—uterine cancer	3.24e-05	0.00012	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	3.22e-05	0.00811	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	3.21e-05	0.00808	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—AKR1C1—uterine cancer	3.18e-05	0.00802	CbGpPWpGaD
Ciprofloxacin—Nausea—Epirubicin—uterine cancer	3.15e-05	0.000116	CcSEcCtD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—AKR1B1—uterine cancer	3.14e-05	0.0079	CbGpPWpGaD
Ciprofloxacin—Vomiting—Doxorubicin—uterine cancer	3.12e-05	0.000115	CcSEcCtD
Ciprofloxacin—Rash—Doxorubicin—uterine cancer	3.09e-05	0.000114	CcSEcCtD
Ciprofloxacin—Dermatitis—Doxorubicin—uterine cancer	3.09e-05	0.000114	CcSEcCtD
Ciprofloxacin—Headache—Doxorubicin—uterine cancer	3.07e-05	0.000114	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—NDC80—uterine cancer	2.99e-05	0.00754	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.95e-05	0.00743	CbGpPWpGaD
Ciprofloxacin—Nausea—Doxorubicin—uterine cancer	2.91e-05	0.000108	CcSEcCtD
Ciprofloxacin—CYP1A2—Arachidonic acid metabolism—AKR1C3—uterine cancer	2.91e-05	0.00733	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—GPX3—uterine cancer	2.8e-05	0.00705	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—NDC80—uterine cancer	2.68e-05	0.00675	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	2.66e-05	0.00671	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.64e-05	0.00666	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.63e-05	0.00664	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Biological oxidations—CYP11A1—uterine cancer	2.63e-05	0.00663	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	2.63e-05	0.00662	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—CYP11A1—uterine cancer	2.6e-05	0.00654	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—POLD1—uterine cancer	2.55e-05	0.00641	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	2.51e-05	0.00633	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—AKR1C3—uterine cancer	2.45e-05	0.00618	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Tryptophan metabolism—CYP19A1—uterine cancer	2.42e-05	0.0061	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—AKR1C1—uterine cancer	2.3e-05	0.0058	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—POLD1—uterine cancer	2.28e-05	0.00574	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	2.16e-05	0.00544	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—RRM2—uterine cancer	2.12e-05	0.00535	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	2.05e-05	0.00518	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	2.03e-05	0.00512	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	2.03e-05	0.00511	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—GPX3—uterine cancer	2.02e-05	0.00509	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	2e-05	0.00503	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.97e-05	0.00496	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.96e-05	0.00493	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Biological oxidations—CYP19A1—uterine cancer	1.94e-05	0.00488	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.93e-05	0.00487	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—CYP19A1—uterine cancer	1.91e-05	0.00481	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	1.9e-05	0.00479	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—RRM2—uterine cancer	1.9e-05	0.00478	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	1.89e-05	0.00476	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	1.88e-05	0.00473	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	1.87e-05	0.00471	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	1.86e-05	0.00469	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	1.8e-05	0.00453	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	1.77e-05	0.00447	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	1.77e-05	0.00445	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—YWHAE—uterine cancer	1.7e-05	0.00429	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MLH1—uterine cancer	1.68e-05	0.00425	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	1.66e-05	0.0042	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	1.62e-05	0.00408	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.59e-05	0.004	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	1.58e-05	0.00398	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	1.57e-05	0.00395	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—YWHAE—uterine cancer	1.52e-05	0.00384	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.51e-05	0.00381	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.49e-05	0.00376	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	1.46e-05	0.00367	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.45e-05	0.00364	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	1.4e-05	0.00353	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	1.39e-05	0.00349	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	1.38e-05	0.00348	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.34e-05	0.00337	CbGpPWpGaD
Ciprofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	1.31e-05	0.0033	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—uterine cancer	1.28e-05	0.00323	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.26e-05	0.00319	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.23e-05	0.00311	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.22e-05	0.00309	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	1.22e-05	0.00307	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—PTEN—uterine cancer	1.18e-05	0.00298	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.18e-05	0.00296	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	1.15e-05	0.00291	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	1.15e-05	0.00289	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDKN2B—uterine cancer	1.14e-05	0.00288	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	1.13e-05	0.00285	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—EP300—uterine cancer	1.13e-05	0.00285	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.11e-05	0.00281	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—uterine cancer	1.1e-05	0.00278	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	1.1e-05	0.00277	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	1.1e-05	0.00277	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	1.07e-05	0.0027	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	1.07e-05	0.0027	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	1.07e-05	0.00269	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—NDUFB11—uterine cancer	1.04e-05	0.00262	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—SRD5A2—uterine cancer	1.04e-05	0.00262	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.02e-05	0.00256	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—BIRC5—uterine cancer	9.88e-06	0.00249	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	9.71e-06	0.00245	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	9.65e-06	0.00243	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	9.65e-06	0.00243	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	9.47e-06	0.00239	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	9.39e-06	0.00237	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—CXCL8—uterine cancer	9.15e-06	0.00231	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	9.14e-06	0.0023	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	9.06e-06	0.00228	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	9.03e-06	0.00228	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	8.84e-06	0.00223	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.76e-06	0.00221	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	8.72e-06	0.0022	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	8.71e-06	0.00219	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	8.7e-06	0.00219	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	8.58e-06	0.00216	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	8.43e-06	0.00212	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.41e-06	0.00212	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	8.31e-06	0.0021	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	8.24e-06	0.00208	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—TP53—uterine cancer	8.08e-06	0.00204	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	7.77e-06	0.00196	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—AKR1B1—uterine cancer	7.52e-06	0.0019	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—STAR—uterine cancer	7.52e-06	0.0019	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—SRD5A2—uterine cancer	7.52e-06	0.0019	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—NDUFB11—uterine cancer	7.52e-06	0.0019	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—VEGFA—uterine cancer	7.43e-06	0.00187	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.35e-06	0.00185	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.35e-06	0.00185	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—uterine cancer	7.32e-06	0.00184	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.11e-06	0.00179	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	6.61e-06	0.00167	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDKN2A—uterine cancer	6.54e-06	0.00165	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	6.51e-06	0.00164	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	6.49e-06	0.00163	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—uterine cancer	6.48e-06	0.00163	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	6.42e-06	0.00162	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—POLD1—uterine cancer	5.9e-06	0.00149	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDKN1B—uterine cancer	5.8e-06	0.00146	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—EP300—uterine cancer	5.69e-06	0.00143	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—SRD5A2—uterine cancer	5.67e-06	0.00143	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—NDUFB11—uterine cancer	5.67e-06	0.00143	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—AKR1C1—uterine cancer	5.52e-06	0.00139	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	5.47e-06	0.00138	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—AKR1B1—uterine cancer	5.44e-06	0.00137	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—STAR—uterine cancer	5.44e-06	0.00137	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.4e-06	0.00136	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—EP300—uterine cancer	5.09e-06	0.00128	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—RRM2—uterine cancer	4.92e-06	0.00124	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—DCN—uterine cancer	4.78e-06	0.0012	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	4.76e-06	0.0012	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—SRD5A2—uterine cancer	4.53e-06	0.00114	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—NDUFB11—uterine cancer	4.53e-06	0.00114	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CYP11A1—uterine cancer	4.5e-06	0.00113	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	4.41e-06	0.00111	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.4e-06	0.00111	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—POLD1—uterine cancer	4.27e-06	0.00108	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—AKR1C3—uterine cancer	4.25e-06	0.00107	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	4.17e-06	0.00105	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.16e-06	0.00105	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—STAR—uterine cancer	4.1e-06	0.00103	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—AKR1B1—uterine cancer	4.1e-06	0.00103	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.06e-06	0.00102	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—AKR1C1—uterine cancer	3.99e-06	0.00101	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	3.87e-06	0.000976	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.67e-06	0.000924	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—TP53—uterine cancer	3.64e-06	0.000918	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—RRM2—uterine cancer	3.56e-06	0.000896	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.5e-06	0.000881	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.5e-06	0.000881	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—DCN—uterine cancer	3.45e-06	0.00087	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—STK11—uterine cancer	3.31e-06	0.000835	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CYP19A1—uterine cancer	3.31e-06	0.000835	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—AKR1B1—uterine cancer	3.28e-06	0.000825	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—STAR—uterine cancer	3.28e-06	0.000825	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CYP11A1—uterine cancer	3.25e-06	0.00082	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.24e-06	0.000816	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—POLD1—uterine cancer	3.22e-06	0.000811	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.12e-06	0.000786	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—AKR1C3—uterine cancer	3.07e-06	0.000774	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—AKR1C1—uterine cancer	3.01e-06	0.000759	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.86e-06	0.000722	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.77e-06	0.000698	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—RRM2—uterine cancer	2.68e-06	0.000676	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—DCN—uterine cancer	2.61e-06	0.000657	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—POLD1—uterine cancer	2.57e-06	0.000648	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—STAR—uterine cancer	2.53e-06	0.000637	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.53e-06	0.000637	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—MTHFR—uterine cancer	2.49e-06	0.000627	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CYP11A1—uterine cancer	2.45e-06	0.000619	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—AKR1C1—uterine cancer	2.4e-06	0.000606	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—STK11—uterine cancer	2.39e-06	0.000603	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CYP19A1—uterine cancer	2.39e-06	0.000603	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.34e-06	0.00059	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—AKR1C3—uterine cancer	2.32e-06	0.000584	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—RRM2—uterine cancer	2.14e-06	0.00054	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—DCN—uterine cancer	2.08e-06	0.000524	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—POLD1—uterine cancer	1.98e-06	0.0005	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.96e-06	0.000494	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.86e-06	0.000468	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.85e-06	0.000466	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—STK11—uterine cancer	1.81e-06	0.000455	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CYP19A1—uterine cancer	1.81e-06	0.000455	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—MTHFR—uterine cancer	1.8e-06	0.000453	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—RRM2—uterine cancer	1.65e-06	0.000417	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—DCN—uterine cancer	1.61e-06	0.000405	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.51e-06	0.000381	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—STK11—uterine cancer	1.44e-06	0.000363	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.44e-06	0.000363	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.43e-06	0.00036	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PTEN—uterine cancer	1.38e-06	0.000349	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—MTHFR—uterine cancer	1.36e-06	0.000342	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.35e-06	0.000341	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—EP300—uterine cancer	1.32e-06	0.000333	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.29e-06	0.000325	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—STK11—uterine cancer	1.11e-06	0.00028	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.11e-06	0.00028	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—MTHFR—uterine cancer	1.08e-06	0.000273	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PTEN—uterine cancer	1e-06	0.000252	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PIK3CA—uterine cancer	9.76e-07	0.000246	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.55e-07	0.000241	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—EP300—uterine cancer	9.54e-07	0.00024	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—MTHFR—uterine cancer	8.36e-07	0.000211	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—AKT1—uterine cancer	7.98e-07	0.000201	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PTEN—uterine cancer	7.55e-07	0.00019	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—EP300—uterine cancer	7.2e-07	0.000181	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PIK3CA—uterine cancer	7.06e-07	0.000178	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PTEN—uterine cancer	6.03e-07	0.000152	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—AKT1—uterine cancer	5.77e-07	0.000145	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—EP300—uterine cancer	5.75e-07	0.000145	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PIK3CA—uterine cancer	5.33e-07	0.000134	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PTEN—uterine cancer	4.65e-07	0.000117	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—EP300—uterine cancer	4.44e-07	0.000112	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—AKT1—uterine cancer	4.35e-07	0.00011	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PIK3CA—uterine cancer	4.25e-07	0.000107	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—AKT1—uterine cancer	3.47e-07	8.75e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.28e-07	8.27e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—AKT1—uterine cancer	2.68e-07	6.76e-05	CbGpPWpGaD
